Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Point-of-care production of therapeutic proteins of good-manufacturing-practice quality.

Adiga R, Al-Adhami M, Andar A, Borhani S, Brown S, Burgenson D, Cooper MA, Deldari S, Frey DD, Ge X, Guo H, Gurramkonda C, Jensen P, Kostov Y, LaCourse W, Liu Y, Moreira A, Mupparapu K, Peñalber-Johnstone C, Pilli M, Punshon-Smith B, Rao A, Rao G, Rauniyar P, Snovida S, Taurani K, Tilahun D, Tolosa L, Tolosa M, Tran K, Vattem K, Veeraraghavan S, Wagner B, Wilhide J, Wood DW, Zuber A.

Nat Biomed Eng. 2018 Sep;2(9):675-686. doi: 10.1038/s41551-018-0259-1. Epub 2018 Jul 9.

PMID:
31015674
2.

Pulmonary Function Tests for the Radiologist.

Tseng HJ, Henry TS, Veeraraghavan S, Mittal PK, Little BP.

Radiographics. 2017 Jul-Aug;37(4):1037-1058. doi: 10.1148/rg.2017160174. Epub 2017 Jun 9. Review.

PMID:
28598732
3.

A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.

Lu C, Lee HS, Pappas GP, Dilling DF, Burger CD, Shifren A, Veeraraghavan S, Chapman JT, Parambil J, Ruoss SJ, Young LR, Hammes SR, Kopras EJ, Roads T, Krischer JP, McCormack FX; Trial of an Aromatase Inhibitor in Lymphangioleiomyomatosis Group.

Ann Am Thorac Soc. 2017 Jun;14(6):919-928. doi: 10.1513/AnnalsATS.201610-824OC.

PMID:
28570161
4.

Spontaneous Pneumothoraces in Patients with Birt-Hogg-Dubé Syndrome.

Gupta N, Kopras EJ, Henske EP, James LE, El-Chemaly S, Veeraraghavan S, Drake MG, McCormack FX.

Ann Am Thorac Soc. 2017 May;14(5):706-713. doi: 10.1513/AnnalsATS.201611-886OC.

5.

Repurposing of a drug scaffold: Identification of novel sila analogues of rimonabant as potent antitubercular agents.

Ramesh R, Shingare RD, Kumar V, Anand A, B S, Veeraraghavan S, Viswanadha S, Ummanni R, Gokhale R, Srinivasa Reddy D.

Eur J Med Chem. 2016 Oct 21;122:723-730. doi: 10.1016/j.ejmech.2016.07.009. Epub 2016 Jul 9.

PMID:
27476117
6.

Simultaneous Quantification of Baricitinib and Methotrexate in Rat Plasma by LC-MS/MS: Application to a Pharmacokinetic Study.

Veeraraghavan S, Thappali SR, Viswanadha S, Vakkalanka S, Rangaswamy M.

Sci Pharm. 2016 Apr-Jun;84(2):347-59. doi: 10.3797/scipharm.1510-08. Epub 2015 Dec 20.

7.

A Potential Structural Switch for Regulating DNA-Binding by TEAD Transcription Factors.

Lee DS, Vonrhein C, Albarado D, Raman CS, Veeraraghavan S.

J Mol Biol. 2016 Jun 19;428(12):2557-2568. doi: 10.1016/j.jmb.2016.03.008. Epub 2016 Mar 22.

8.

A 49-Year-Old Man With Cirrhosis and Pulmonary Fibrosis.

Rajaram P, Little B, Norvell JP, McLemore M, Veeraraghavan S.

Chest. 2016 Feb;149(2):e57-e60. doi: 10.1016/j.chest.2015.06.010.

PMID:
26867856
9.

Design, Synthesis, and Identification of Silicon Incorporated Oxazolidinone Antibiotics with Improved Brain Exposure.

Seetharamsingh B, Ramesh R, Dange SS, Khairnar PV, Singhal S, Upadhyay D, Veeraraghavan S, Viswanadha S, Vakkalanka S, Reddy DS.

ACS Med Chem Lett. 2015 Oct 26;6(11):1105-10. doi: 10.1021/acsmedchemlett.5b00213. eCollection 2015 Nov 12.

10.

The Spectrum of Interstitial Lung Disease in Connective Tissue Disease.

Henry TS, Little BP, Veeraraghavan S, Bhalla S, Elicker BM.

J Thorac Imaging. 2016 Mar;31(2):65-77. doi: 10.1097/RTI.0000000000000191. Review.

PMID:
26554660
11.

Early detection of lung cancer in China: The immediate imperative.

Veeraraghavan S, Ramalingam SS, Khuri FR.

Cancer. 2015 Sep 1;121 Suppl 17:3055-7. doi: 10.1002/cncr.29601. No abstract available.

12.

Accuracy of chest high-resolution computed tomography in diagnosing diffuse cystic lung diseases.

Gupta N, Meraj R, Tanase D, James LE, Seyama K, Lynch DA, Akira M, Meyer CA, Ruoss SJ, Burger CD, Young LR, Almoosa KF, Veeraraghavan S, Barker AF, Lee AS, Dilling DF, Inoue Y, Cudzilo CJ, Zafar MA, McCormack FX.

Eur Respir J. 2015 Oct;46(4):1196-9. doi: 10.1183/13993003.00570-2015. Epub 2015 Jul 9. No abstract available.

13.

Bronchiectasis: Mechanisms and Imaging Clues of Associated Common and Uncommon Diseases.

Milliron B, Henry TS, Veeraraghavan S, Little BP.

Radiographics. 2015 Jul-Aug;35(4):1011-30. doi: 10.1148/rg.2015140214. Epub 2015 May 29. Review.

PMID:
26024063
14.

Pharmacologic therapies for idiopathic pulmonary fibrosis, past and future.

Staitieh BS, Renzoni EA, Veeraraghavan S.

Ann Med. 2015 Mar;47(2):100-5. doi: 10.3109/07853890.2014.991751. Epub 2015 Jan 22. Review.

15.

Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC-MS/MS: application to a pharmacokinetic study.

Veeraraghavan S, Viswanadha S, Thappali S, Govindarajulu B, Vakkalanka S, Rangasamy M.

J Pharm Biomed Anal. 2015 Mar 25;107:151-8. doi: 10.1016/j.jpba.2014.11.041. Epub 2014 Dec 25.

PMID:
25594893
16.

MAT2A mutations predispose individuals to thoracic aortic aneurysms.

Guo DC, Gong L, Regalado ES, Santos-Cortez RL, Zhao R, Cai B, Veeraraghavan S, Prakash SK, Johnson RJ, Muilenburg A, Willing M, Jondeau G, Boileau C, Pannu H, Moran R, Debacker J; GenTAC Investigators, National Heart, Lung, and Blood Institute Go Exome Sequencing Project; Montalcino Aortic Consortium, Bamshad MJ, Shendure J, Nickerson DA, Leal SM, Raman CS, Swindell EC, Milewicz DM.

Am J Hum Genet. 2015 Jan 8;96(1):170-7. doi: 10.1016/j.ajhg.2014.11.015. Epub 2014 Dec 31.

17.

Pulmonary effects of synthetic marijuana: chest radiography and CT findings.

Berkowitz EA, Henry TS, Veeraraghavan S, Staton GW Jr, Gal AA.

AJR Am J Roentgenol. 2015 Apr;204(4):750-7. doi: 10.2214/AJR.14.13138. Epub 2014 Dec 26.

PMID:
25541904
18.

Tobacco control: up in E-smoke?

Veeraraghavan S.

Cancer. 2014 Nov 15;120(22):3430-2. doi: 10.1002/cncr.28810. Epub 2014 Sep 22. No abstract available.

19.

DDD-028: a potent potential non-opioid, non-cannabinoid analgesic for neuropathic and inflammatory pain.

Rajagopalan P, Tracey H, Chen Z, Bandyopadhyaya A, Veeraraghavan S, Rajagopalan DR, Salvemini D, McPhee I, Viswanadha S, Rajagopalan R.

Bioorg Med Chem Lett. 2014 Jul 15;24(14):3088-91. doi: 10.1016/j.bmcl.2014.05.016. Epub 2014 May 14.

PMID:
24863744
20.

Global solutions of restricted open-shell Hartree-Fock theory from semidefinite programming with applications to strongly correlated quantum systems.

Veeraraghavan S, Mazziotti DA.

J Chem Phys. 2014 Mar 28;140(12):124106. doi: 10.1063/1.4868242.

PMID:
24697423
21.

Simultaneous quantification of ruxolitinib and nilotinib in rat plasma by LC-MS/MS: application to a pharmacokinetic study.

Veeraraghavan S, Thappali S, Viswanadha S, Chennupati S, Nalla S, Golla M, Vakkalanka S, Rangasamy M.

J Pharm Biomed Anal. 2014 Jun;94:125-31. doi: 10.1016/j.jpba.2014.01.040. Epub 2014 Feb 3.

PMID:
24561338
22.

Simultaneous quantification of idelalisib, fludarabine and lenalidomide in rat plasma by using high-performance liquid chromatography coupled with heated electrospray ionization tandem mass spectrometry.

Veeraraghavan S, Thappali S, Viswanadha S, Nalla S, Chennupati S, Golla M, Vakkalanka S, Rangasamy M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Feb 15;949-950:63-9. doi: 10.1016/j.jchromb.2014.01.001. Epub 2014 Jan 8.

PMID:
24463402
23.

A 22-year-old woman with bronchiectasis and a mediastinal mass.

Hunt WR, Allam JS, Sica G, Little BP, Veeraraghavan S.

Chest. 2013 Oct;144(4):1406-1409. doi: 10.1378/chest.13-0647. No abstract available.

24.

Empiric treatment of focal organizing pneumonia in a patient with a low-risk lung mass.

Alikhan M, Veeraraghavan S.

Case Rep Pulmonol. 2013;2013:340202. doi: 10.1155/2013/340202. Epub 2013 Jul 30.

25.

Simultaneous quantitation of IC87114, roflumilast and its active metabolite roflumilast N-oxide in plasma by LC-MS/MS: application for a pharmacokinetic study.

Thappali SR, Varanasi KV, Veeraraghavan S, Vakkalanka SK, Mukkanti K.

J Mass Spectrom. 2012 Dec;47(12):1612-9. doi: 10.1002/jms.3103.

PMID:
23280750
26.

Simultaneous determination of methotrexate, dasatinib and its active metabolite N- deshydroxyethyl dasatinib in rat plasma by LC-MS/MS: method validation and application to pharmacokinetic study.

Thappali SR, Varanasi KV, Veeraraghavan S, Vakkalanka SK, Khagga M.

Arzneimittelforschung. 2012 Dec;62(12):624-30. doi: 10.1055/s-0032-1327702. Epub 2012 Nov 8.

PMID:
23138519
27.

Effect of multidose cilostazol on pharmacokinetic and lipid profile of atorvastatin in male Wistar rats.

Vats R, Varanasi KV, Arla R, Veeraraghavan S, Rajak S, Murthy AN.

J Pharm Pharmacol. 2012 Nov;64(11):1638-45. doi: 10.1111/j.2042-7158.2012.01542.x. Epub 2012 May 29.

PMID:
23058051
28.

Simultaneous Determination of Celecoxib, Erlotinib, and its Metabolite Desmethyl-Erlotinib (OSI-420) in Rat Plasma by Liquid chromatography/Tandem Mass Spectrometry with Positive/Negative Ion-Switching Electrospray Ionisation.

Thappali SR, Varanasi K, Veeraraghavan S, Arla R, Chennupati S, Rajamanickam M, Vakkalanka S, Khagga M.

Sci Pharm. 2012 Jul-Sep;80(3):633-46. Epub 2012 Jun 18.

29.
30.

Influence of grapefruit juice on the pharmacokinetics of diltiazem in Wistar rats upon single and multiple dosage regimens.

Boddu SP, Yamsani MR, Potharaju S, Veeraraghavan S, Rajak S, Kuma SV, Avery BA, Repka MA, Varanasi VS.

Pharmazie. 2009 Aug;64(8):525-31.

31.

Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease.

Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, Kim DH, Pannu H, Willing MC, Sparks E, Pyeritz RE, Singh MN, Dalman RL, Grotta JC, Marian AJ, Boerwinkle EA, Frazier LQ, LeMaire SA, Coselli JS, Estrera AL, Safi HJ, Veeraraghavan S, Muzny DM, Wheeler DA, Willerson JT, Yu RK, Shete SS, Scherer SE, Raman CS, Buja LM, Milewicz DM.

Am J Hum Genet. 2009 May;84(5):617-27. doi: 10.1016/j.ajhg.2009.04.007. Epub 2009 Apr 30.

32.

Effect of pentoxifylline on the pharmacokinetics of rosiglitazone in Wistar rats.

Varanasi KK, Potharaju S, Rajak S, Veeraraghavan S, Mallick P, Vakkalanka SK.

Methods Find Exp Clin Pharmacol. 2008 Sep;30(7):537-42. doi: 10.1358/mf.2008.30.7.1233243.

PMID:
18985182
33.

Molecular basis for proline- and arginine-rich peptide inhibition of proteasome.

Anbanandam A, Albarado DC, Tirziu DC, Simons M, Veeraraghavan S.

J Mol Biol. 2008 Dec 5;384(1):219-27. doi: 10.1016/j.jmb.2008.09.021. Epub 2008 Sep 16.

34.

Validated high performance liquid chromatographic method for simultaneous determination of rosiglitazone, cilostazol, and 3,4-dehydro-cilostazol in rat plasma and its application to pharmacokinetics.

Varanasi VS, Veeraraghavan S, Potharaju S, Thappali RS, Raghavan R, Vakkalanka VS.

Arzneimittelforschung. 2008;58(6):288-96. doi: 10.1055/s-0031-1296509.

PMID:
18677971
35.

Interstitial lung disease in systemic sclerosis: a simple staging system.

Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, Corte TJ, Sander CR, Ratoff J, Devaraj A, Bozovic G, Denton CP, Black CM, du Bois RM, Wells AU.

Am J Respir Crit Care Med. 2008 Jun 1;177(11):1248-54. doi: 10.1164/rccm.200706-877OC. Epub 2008 Mar 27.

PMID:
18369202
36.

Amino acid substitutions at proline 220 of beta-tubulin confer resistance to paclitaxel and colcemid.

Yin S, Cabral F, Veeraraghavan S.

Mol Cancer Ther. 2007 Oct;6(10):2798-806.

37.

Fast (4,3)D GFT-TS NMR for NOESY of small to medium-sized proteins.

Xia Y, Veeraraghavan S, Zhu Q, Gao X.

J Magn Reson. 2008 Jan;190(1):142-8. Epub 2007 Sep 22.

PMID:
17923427
38.

Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.

Goh NS, Veeraraghavan S, Desai SR, Cramer D, Hansell DM, Denton CP, Black CM, du Bois RM, Wells AU.

Arthritis Rheum. 2007 Jun;56(6):2005-12.

39.

Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domain.

Anbanandam A, Albarado DC, Nguyen CT, Halder G, Gao X, Veeraraghavan S.

Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17225-30. Epub 2006 Nov 3.

40.

Genetics of pulmonary fibrosis.

du Bois RM, Kangesan I, Veeraraghavan S.

Semin Respir Crit Care Med. 2003 Apr;24(2):205-12.

PMID:
16088540
41.

Comparing microstructural and macrostructural development of the cerebral cortex in premature newborns: diffusion tensor imaging versus cortical gyration.

Deipolyi AR, Mukherjee P, Gill K, Henry RG, Partridge SC, Veeraraghavan S, Jin H, Lu Y, Miller SP, Ferriero DM, Vigneron DB, Barkovich AJ.

Neuroimage. 2005 Sep;27(3):579-86.

PMID:
15921934
42.

Gene expression profiling reveals novel TGFbeta targets in adult lung fibroblasts.

Renzoni EA, Abraham DJ, Howat S, Shi-Wen X, Sestini P, Bou-Gharios G, Wells AU, Veeraraghavan S, Nicholson AG, Denton CP, Leask A, Pearson JD, Black CM, Welsh KI, du Bois RM.

Respir Res. 2004 Nov 30;5:24.

43.

CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.

Desai SR, Veeraraghavan S, Hansell DM, Nikolakopolou A, Goh NS, Nicholson AG, Colby TV, Denton CP, Black CM, du Bois RM, Wells AU.

Radiology. 2004 Aug;232(2):560-7.

PMID:
15286324
44.

Mapping of the immunodominant T cell epitopes of the protein topoisomerase I.

Veeraraghavan S, Renzoni EA, Jeal H, Jones M, Hammer J, Wells AU, Black CM, Welsh KI, du Bois RM.

Ann Rheum Dis. 2004 Aug;63(8):982-7.

45.

Intra-allelic suppression of a mutation that stabilizes microtubules and confers resistance to colcemid.

Wang Y, Veeraraghavan S, Cabral F.

Biochemistry. 2004 Jul 20;43(28):8965-73.

PMID:
15248754
46.

(3,2)D GFT-NMR experiments for fast data collection from proteins.

Xia Y, Zhu G, Veeraraghavan S, Gao X.

J Biomol NMR. 2004 Aug;29(4):467-76.

PMID:
15243178
47.

Organizing pneumonia: perilobular pattern at thin-section CT.

Ujita M, Renzoni EA, Veeraraghavan S, Wells AU, Hansell DM.

Radiology. 2004 Sep;232(3):757-61. Epub 2004 Jun 30.

PMID:
15229349
48.

Early laminar organization of the human cerebrum demonstrated with diffusion tensor imaging in extremely premature infants.

Maas LC, Mukherjee P, Carballido-Gamio J, Veeraraghavan S, Miller SP, Partridge SC, Henry RG, Barkovich AJ, Vigneron DB.

Neuroimage. 2004 Jul;22(3):1134-40.

PMID:
15219585
49.

The TNF-863A allele strongly associates with anticentromere antibody positivity in scleroderma.

Sato H, Lagan AL, Alexopoulou C, Vassilakis DA, Ahmad T, Pantelidis P, Veeraraghavan S, Renzoni E, Denton C, Black C, Wells AU, du Bois RM, Welsh KI.

Arthritis Rheum. 2004 Feb;50(2):558-64.

50.

BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia.

Veeraraghavan S, Latsi PI, Wells AU, Pantelidis P, Nicholson AG, Colby TV, Haslam PL, Renzoni EA, du Bois RM.

Eur Respir J. 2003 Aug;22(2):239-44.

Supplemental Content

Loading ...
Support Center